The First Autopsy Case of Fatal Acute Cardiac Failure after Administration of Carfilzomib in a Patient with Multiple Myeloma

Carfilzomib (CFZ) improves progression-free survival for patients with relapsed or refractory multiple myeloma (MM) but has shown higher frequency of cardiovascular adverse events (CVAEs) than other proteasome inhibitors. We report the first autopsy case of acute death from cardiac failure shortly a...

Descripción completa

Detalles Bibliográficos
Autores principales: Takakuwa, Teruhito, Otomaru, Ippei, Araki, Taku, Miura, Akiko, Fujitani, Yotaro, Mochizuki, Yasuhide, Miyagi, Yoshimi, Senzaki, Hideto, Yamamura, Ryosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512067/
https://www.ncbi.nlm.nih.gov/pubmed/31183224
http://dx.doi.org/10.1155/2019/1816287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512067/
https://www.ncbi.nlm.nih.gov/pubmed/31183224
http://dx.doi.org/10.1155/2019/1816287

Ejemplares similares